Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Impel Pharmaceuticals Inc
(NQ:
IMPL
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EST, Dec 15, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Impel Pharmaceuticals Inc
< Previous
1
2
3
4
5
6
Next >
Impel Commences Mid-Stage Autism Spectrum Disorder Study
July 19, 2022
Impel Pharmaceuticals (NASDAQ: IMPL) has dosed the first patient in a Phase 2a proof-of-concept study of INP105, nasal olanzapine, a widely used atypical, second-generation antipsychotic.
Via
Benzinga
Impel NeuroPharma's Return On Capital Employed Insights
June 21, 2022
Impel NeuroPharma (NASDAQ:IMPL) brought in sales totaling $1.76 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 9.0%, resulting in a loss of $26.97 million.
Via
Benzinga
Impel Pharmaceuticals: Q1 Earnings Insights
May 16, 2022
Impel Pharmaceuticals (NASDAQ:IMPL) reported its Q1 earnings results on Monday, May 16, 2022 at 08:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Earnings Scheduled For May 16, 2022
May 16, 2022
Companies Reporting Before The Bell • AcelRx Pharmaceuticals (NASDAQ:ACRX) is estimated to report quarterly loss at $0.06 per share on revenue of $550.00 thousand.
Via
Benzinga
Mizuho Remains Bullish On This Small-Cap Stock's Migraine Candidate, But Why Did It Cut Price Target
May 13, 2022
Mizuho Securities says that the Satsuma Pharmaceuticals Inc (NASDAQ: STSA) story is essentially unchanged. It remains bullish on STS101's potential as an effective, safe, and reliable intranasal...
Via
Benzinga
Impel NeuroPharma Earnings Preview
May 13, 2022
Impel NeuroPharma (NASDAQ:IMPL) is set to give its latest quarterly earnings report on Monday, 2022-05-16. Here's what investors need to know before the announcement. Analysts estimate that Impel...
Via
Benzinga
66 Biggest Movers From Yesterday
May 03, 2022
Gainers Better Therapeutics, Inc. (NASDAQ: BTTX) shares surged 120.4% to close at $2.01 on Monday following a 5% drop on Friday. SoundHound AI, Inc. (NASDAQ: SOUN) shares surged...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
March 24, 2022
Gainers BiondVax Pharmaceuticals (NASDAQ:BVXV) shares moved upwards by 55.5% to $2.13 during Thursday's pre-market session. The market value of their outstanding...
Via
Benzinga
Earnings Scheduled For March 24, 2022
March 24, 2022
Companies Reporting Before The Bell • iHuman (NYSE:IH) is likely to report earnings for its fourth quarter. • Pioneer Muni High Inc (NYSE:MAV) is expected to...
Via
Benzinga
Benzinga's After-Hours Movers & News: Williams-Sonoma, PagerDuty And More
March 16, 2022
Benzinga’s “After-Hours Movers & News” highlights the biggest movers of the day. The information on the price action is collected using Benzinga Pro's...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
March 16, 2022
Gainers
Via
Benzinga
Impel Neuro's Trudhesa Nasal Spray Migraine Treatment Performed Better Than Expected In Q4
January 18, 2022
Impel NeuroPharma Inc (NASDAQ: IMPL) stated that since the October 2021 commercial launch, the performance of Trudhesa has exceeded expectations with over 4,200...
Via
Benzinga
41 Stocks Moving In Monday's Mid-Day Session
November 15, 2021
Gainers Casper Sleep Inc. (NYSE: CSPR) shares climbed 87.1% to $6.64 after the company agreed to be acquired by Durational Capital Management. The company also reported Q3...
Via
Benzinga
Earnings Scheduled For November 15, 2021
November 15, 2021
Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is estimated to report earnings for its third quarter. • Tyson Foods (NYSE:TSN) is estimated to...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
September 28, 2021
Gainers Sonoma Pharmaceuticals (NASDAQ:SNOA) shares increased by 35.02% to $7.22 during Tuesday's regular session. Trading volume for this security as of 12:30 EST is...
Via
Benzinga
60 Biggest Movers From Friday
September 13, 2021
Gainers IVERIC bio, Inc. (NASDAQ: ISEE) shares surged 62.5% to close at $14.12 on Friday after Apellis Pharmaceuticals reported results from its Phase 3 DERBY and OAKS studies in...
Via
Benzinga
Why Impel NeuroPharma Dived by 24% Today
September 10, 2021
For investors, the company's price for a new share issue isn't right.
Via
The Motley Fool
Mid-Afternoon Market Update: Dow Slides Over 100 Points; Echo Global Logistics Shares Spike Higher
September 10, 2021
Toward the end of trading Friday, the Dow traded down 0.31% to 34,772.74 while the NASDAQ fell 0.27% to 15,207.42. The S&P also fell, dropping 0.28% to 4,480.86. The U.S. has...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Friday's Intraday Session
September 10, 2021
Gainers IVERIC bio (NASDAQ:ISEE) shares increased by 63.11% to $14.18 during Friday's regular session. IVERIC bio's stock is trading at a volume of 120.3 million...
Via
Benzinga
Mid-Day Market Update: Crude Oil Rises Over 2%; Apellis Pharmaceuticals Shares Plunge
September 10, 2021
Midway through trading Friday, the Dow traded down 0.40% to 34,739.37 while the NASDAQ fell 0.06% to 15,238.92. The S&P also fell, dropping 0.21% to 4,483.84. The U.S. has the...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
41 Stocks Moving In Friday's Mid-Day Session
September 10, 2021
Gainers IVERIC bio, Inc. (NASDAQ: ISEE) shares climbed 64.4% to $14.29 after Apellis Pharmaceuticals reported results from its Phase 3 DERBY and OAKS studies in geographic...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
September 10, 2021
Gainers IVERIC bio (NASDAQ:ISEE) stock increased by 65.36% to $14.37 during Friday's pre-market session. The company's market cap stands at $1.4 billion. T2...
Via
Benzinga
Impel NeuroPharma To Raise $45M Via Equity Offering
September 10, 2021
Impel NeuroPharma Inc's (NASDAQ: IMPL) has priced its previously announced underwritten public offering of 3 million shares at $15.00 per share for gross...
Via
Benzinga
20 Stocks Moving in Friday's Pre-Market Session
September 10, 2021
Gainers IVERIC bio, Inc. (NASDAQ: ISEE) rose 29.6% to $11.26 in pre-market trading. Iveric Bio recently reported inducement grants under Nasdaq Listing Rule 5635(c)(4). T2...
Via
Benzinga
48 Biggest Movers From Yesterday
September 10, 2021
Gainers Rocket Lab USA, Inc. (NASDAQ: RKLB) jumped 37.3% to settle at $20.72. Rocket Lab reported 1H sales of $29.5 million and announced it has been awarded a contract to deploy...
Via
Benzinga
Why Impel NeuroPharma Stock Blasted 27% Higher Thursday
September 09, 2021
A big sell-off in the stock is followed by a sudden bull rush, days after the company wins its first FDA approval.
Via
The Motley Fool
Exposures
Product Safety
12 Health Care Stocks Moving In Thursday's Intraday Session
September 09, 2021
Gainers Impel NeuroPharma (NASDAQ:IMPL) shares increased by 22.16% to $20.29 during Thursday's regular session. Trading volume for this security as of 12:30 EST is 1.1...
Via
Benzinga
30 Stocks Moving In Wednesday's Mid-Day Session
September 08, 2021
Gainers Kadmon Holdings, Inc. (NASDAQ: KDMN) shares jumped 72.6% to $9.15. Sanofi announced Wednesday it has agreed to acquire New York-based biopharma Kadmon in a $1.9 billion...
Via
Benzinga
54 Biggest Movers From Yesterday
September 09, 2021
Gainers eFFECTOR Therapeutics, Inc. (NASDAQ: EFTR) shares jumped 111.8% to settle at $27.17 on Wednesday after jumping 50% on Tuesday. Helbiz, Inc. (NASDAQ: HLBZ) gained 84% to...
Via
Benzinga
The Daily Biotech Pulse: MacroGenics' Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA's FDA Nod
September 08, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 7) Adial Pharmaceuticals, Inc...
Via
Benzinga
Exposures
Product Safety
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.